JS On Co., Ltd. (CEO Jeong Joo-hwan) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
JS On, established in 2013, is a company that has been researching and developing treatment devices that can be used for various types of pain with the goal of realizing a ‘pain-free life.’ To this end, the company explains that it is strengthening its competitiveness and networking capabilities by securing its own technological capabilities and focusing on registering domestic and international technology patents. In addition, the company succeeded in establishing a foundation for entry into the global market by obtaining licenses such as ISO 13485 and CE certification.
In this exhibition, JS On presents the ‘HIPER’ series, a high-frequency thermal therapy device product line. The initial model, ‘HIPER-500’, was produced based on the ‘automatically variable high-frequency thermal therapy device’ patent registered in December 2014. It exerts the effect of relieving various musculoskeletal inflammation and pain by disseminating high-frequency energy to the human body and inducing deep heat to generate specific stimulation.
In particular, an SCI-level paper proving the effectiveness of treating back and shoulder pain has been registered, and clinical trials for other areas are also reportedly nearing completion.
In addition, the probes, which are composed of two pairs, are insulated with special materials to increase convenience and safety so that they can be used anywhere on the human body. Based on these characteristics, it obtained product approval as a ‘high-frequency stimulator’ from the Ministry of Food and Drug Safety in August 2, and is currently continuously supplying it to medium to large hospitals.
A JSON official said, “The HIPER series has concentrated technology that differentiates it from existing medical devices, and we are confident that it is a product that dramatically relieves pain.” He added, “We have already applied for patents in the United States, Europe, China, and India. “We expect to be able to expand our sales channels in overseas markets through KIMES 2023,” he said, explaining the reason for participating in this exhibition.
He added, “Our goal is to develop more innovative and competitive medical devices and contribute to the trend of growing interest in healthy lifespan and grow into a global company specializing in therapeutic devices.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.